As of 2024-07-27, the Relative Valuation of Corcept Therapeutics Inc (CORT) is 18.51 USD. This relative valuation is based on P/E multiples. With the latest stock price at 35.60 USD, the upside of Corcept Therapeutics Inc based on Relative Valuation is -48.0%.
The range of the Relative Valuation is 15.10 - 23.43 USD.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 20.4x | 13.7x |
| Forward P/E multiples | 15.6x - 20.1x | 18.4x |
| Fair Price | 15.10 - 23.43 | 18.51 |
| Upside | -57.6% - -34.2% | -48.0% |
| Date | P/E |
| 2024-07-26 | 31.40 |
| 2024-07-25 | 30.76 |
| 2024-07-24 | 30.42 |
| 2024-07-23 | 30.49 |
| 2024-07-22 | 30.50 |
| 2024-07-19 | 29.89 |
| 2024-07-18 | 29.37 |
| 2024-07-17 | 29.32 |
| 2024-07-16 | 29.41 |
| 2024-07-15 | 28.54 |
| 2024-07-12 | 27.79 |
| 2024-07-11 | 27.50 |
| 2024-07-10 | 27.01 |
| 2024-07-09 | 26.38 |
| 2024-07-08 | 26.03 |
| 2024-07-05 | 26.54 |
| 2024-07-03 | 26.91 |
| 2024-07-02 | 27.84 |
| 2024-07-01 | 28.82 |
| 2024-06-28 | 28.66 |
| 2024-06-27 | 28.28 |
| 2024-06-26 | 27.88 |
| 2024-06-25 | 26.81 |
| 2024-06-24 | 26.99 |
| 2024-06-21 | 26.50 |
| 2024-06-20 | 25.94 |
| 2024-06-18 | 24.83 |
| 2024-06-17 | 25.22 |
| 2024-06-14 | 25.56 |
| 2024-06-13 | 27.80 |
| 2024-06-12 | 28.79 |
| 2024-06-11 | 28.93 |
| 2024-06-10 | 28.17 |
| 2024-06-07 | 29.38 |
| 2024-06-06 | 30.42 |
| 2024-06-05 | 30.38 |
| 2024-06-04 | 29.00 |
| 2024-06-03 | 27.61 |
| 2024-05-31 | 26.61 |
| 2024-05-30 | 27.53 |
| 2024-05-29 | 27.81 |
| 2024-05-28 | 27.89 |
| 2024-05-24 | 24.28 |
| 2024-05-23 | 24.56 |
| 2024-05-22 | 25.25 |
| 2024-05-21 | 25.41 |
| 2024-05-20 | 25.48 |
| 2024-05-17 | 24.78 |
| 2024-05-16 | 24.29 |
| 2024-05-15 | 24.55 |